B M Errichi, M R Cesarone, G Belcaro, R Marinucci, A Ricci, A Ippolito, R Brandolini, G Vinciguerra, M Dugall, A Felicita, L Pellegrini, G Gizzi, M Ruffini, G Acerbi, P Bavera, A Di Renzo, M Corsi, M Scoccianti, M Hosoi, M Lania
The aim of this study was to evaluate the prevention of recurrent deep vein thrombosis (R-DVT) with an oral antithrombotic agent (sulodexide) in moderate to high-risk subjects. A group of 405 patients was included into the multicenter registry. Both compression and an exercise program were used as well as a risk-factors control plan. After diagnosis of DVT, patients were treated with oral anticoagulants for 6 months. At the end of this period a coagulation study was made and patients started treatment with oral sulodexide capsules for a period of 24 months...
May 2004: Angiology